IBDEI0W4 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15062,0)
 ;;=D51.3^^56^638^31
 ;;^UTILITY(U,$J,358.3,15062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15062,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Dietary
 ;;^UTILITY(U,$J,358.3,15062,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,15062,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,15063,0)
 ;;=D51.0^^56^638^28
 ;;^UTILITY(U,$J,358.3,15063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15063,1,3,0)
 ;;=3^Pernicious Anemia
 ;;^UTILITY(U,$J,358.3,15063,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,15063,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,15064,0)
 ;;=D50.0^^56^638^3
 ;;^UTILITY(U,$J,358.3,15064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15064,1,3,0)
 ;;=3^Anemia d/t Blood Loss (Chronic)
 ;;^UTILITY(U,$J,358.3,15064,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,15064,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,15065,0)
 ;;=E11.21^^56^638^18
 ;;^UTILITY(U,$J,358.3,15065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15065,1,3,0)
 ;;=3^DM Type 2 w/ Nephropathy
 ;;^UTILITY(U,$J,358.3,15065,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,15065,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,15066,0)
 ;;=E11.22^^56^638^8
 ;;^UTILITY(U,$J,358.3,15066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15066,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,15066,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,15066,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,15067,0)
 ;;=E11.29^^56^638^19
 ;;^UTILITY(U,$J,358.3,15067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15067,1,3,0)
 ;;=3^DM Type 2 w/ Other Diabetic Kidney Complication
 ;;^UTILITY(U,$J,358.3,15067,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,15067,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,15068,0)
 ;;=E11.311^^56^638^20
 ;;^UTILITY(U,$J,358.3,15068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15068,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diabetic Retinopathy w/ Macular edema
 ;;^UTILITY(U,$J,358.3,15068,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,15068,2)
 ;;=^5002632
 ;;^UTILITY(U,$J,358.3,15069,0)
 ;;=E11.319^^56^638^21
 ;;^UTILITY(U,$J,358.3,15069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15069,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diabetic Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,15069,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,15069,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,15070,0)
 ;;=E11.40^^56^638^10
 ;;^UTILITY(U,$J,358.3,15070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15070,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,15070,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,15070,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,15071,0)
 ;;=E11.41^^56^638^9
 ;;^UTILITY(U,$J,358.3,15071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15071,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Mononeuropathy
 ;;^UTILITY(U,$J,358.3,15071,1,4,0)
 ;;=4^E11.41
 ;;^UTILITY(U,$J,358.3,15071,2)
 ;;=^5002645
 ;;^UTILITY(U,$J,358.3,15072,0)
 ;;=E11.42^^56^638^13
 ;;^UTILITY(U,$J,358.3,15072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15072,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,15072,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,15072,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,15073,0)
 ;;=E11.43^^56^638^7
 ;;^UTILITY(U,$J,358.3,15073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15073,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,15073,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,15073,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,15074,0)
 ;;=E11.51^^56^638^11
 ;;^UTILITY(U,$J,358.3,15074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15074,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Peripheral Angiopathy w/o Gangrene
